Intervention

Quality of Life questionnaires

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting0

Common conditions5

Lead sponsors shown2

Clinical trials

2 shown

Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)NCT06663189 · 2025-01-01

NOT_YET_RECRUITING

LIFE - Lung Cancer, Immunotherapy, Frailty, EffectNCT03870464 · 2018-04-01

ACTIVE_NOT_RECRUITING

Common conditions

Brain Metastases1 Non-small Cell Lung Cancer1 Quality of Life1 Relapsing-remitting Multiple Sclerosis (RRMS)1 Venous Thromboembolism1

Leading sponsors

University Hospital, Strasbourg, France 1 University of Southern Denmark 1

Trial status mix

ACTIVE_NOT_RECRUITING1

NOT_YET_RECRUITING1

Phase mix

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.